The drugmaker has won an appeal against NICE's recent final draft guidance on Sarclisa (isatuximab) as a regimen alongside ...

Myeloma UK said the illness was treatable in the majority of cases despite there being no known cure. "Treatment is aimed at controlling the disease, relieving the complications and symptoms it ...

After he stopped responding to several different therapies aimed at prolonging his life, doctors advised him to try a drug ...

Sanofi has hit back on a decision by NICE not ... Shelagh McKinlay, director of research and advocacy at patient organisation Myeloma UK, said the decision is “a huge blow” to patients ...

Mia Savage Mia is one of about 5,900 people diagnosed with myeloma in the UK each year By the time ... her experience of living with the disease for Myeloma Awareness Week because she wants ...

Sanofi SNY announced that the FDA has approved the label expansion for the use of its multiple myeloma (MM ... VRd-combination reduced the risk of disease progression or death by 40% versus ...

including rare cancers such as multiple myeloma, acute myeloid leukemia, and certain types of lymphomas, as well as gastrointestinal and lung cancers. Sanofi and Orano Med are members of the Paris ...

Sanofi has turned to dealmaking several times since to further build out its rare disease business. Over the past year alone, the French pharmaceutical giant nabbed rights to an experimental drug ...

A few diet tips can make it easier to eat well. You’ll need to look out for infections with multiple myeloma. The disease and its treatment make infections more likely. Peripheral neuropathy may ...

Better awareness among ... Rhys Owens, of Myeloma UK, said the charity is trying to stress to family doctors the impact of ...

For its “Allegra Airways” campaign, the allergy medication brand used real-time pollen and air pollution data to find pockets ...

In sustained rare disease push, Recordati lays out $825M upfront to acquire Sanofi's CAD drug Enjaymo Meanwhile, Sanofi saw revenues for its consumer health arm, Opella, grow 7.9%. Earlier this ...